Autonomic Nervous System Drugs Practice Questions

Q: Which enzymes are involved in the degradation of epinephrine?

Catechol-O-methyltransferase. The degradation of catecholamines (Epinephrine, Norepinephrine, and Dopamine) is primarily mediated by two key enzymes: **Catechol-O-methyltransferase (COMT)** and **Monoamine Oxidase (MAO)** [1]. * **Why COMT is correct:** COMT is located extraneuronally (in the liver, kidneys, and smooth muscles) [1]. It transfers a methyl group from S-adenosylmethionine to the hydroxyl group of the catechol ring. Epinephrine is metabolized by COMT into **Metanephrine**, which is then further converted into **Vanillylmandelic acid (VMA)**, the primary urinary metabolite used to diagnose pheochromocytoma. * **Why other options are incorrect:** * **Cholinesterase:** This enzyme (specifically Acetylcholinesterase) is responsible for the rapid hydrolysis of **Acetylcholine** at cholinergic synapses [1]. It has no role in catecholamine metabolism. * **Anticholinesterases:** These are drugs (e.g., Neostigmine, Physostigmine) that *inhibit* cholinesterase; they are not enzymes involved in degradation. * **Oxidases:** While Monoamine Oxidase (MAO) is involved in epinephrine degradation, the term "Oxidases" is too broad and non-specific in a pharmacological context compared to the definitive action of COMT. **High-Yield NEET-PG Pearls:** 1. **Metabolic End-product:** The final common metabolite of both Epinephrine and Norepinephrine is **VMA**. High urinary VMA levels are a hallmark of **Pheochromocytoma**. 2. **Location:** MAO is found in the outer mitochondrial membrane (intraneuronal), while COMT is primarily extraneuronal [1]. 3. **Clinical Correlation:** COMT inhibitors like **Entacapone** and **Tolcapone** are used in Parkinson’s disease to prevent the peripheral degradation of Levodopa.

Q: Methoctramine is a

Selective M2 antagonist. ### Explanation **Correct Option: B. Selective M2 antagonist** Muscarinic receptors are G-protein coupled receptors (GPCRs) categorized into five subtypes ($M_1$ to $M_5$). **Methoctramine** is a polymethylene tetraamine derivative that acts as a potent and highly **selective competitive antagonist at $M_2$ receptors**. $M_2$ receptors are primarily located in the heart (SA node, AV node, and atria), where they mediate bradycardia and decreased conduction velocity via $G_i$ proteins. By blocking these receptors, Methoctramine prevents the inhibitory effects of acetylcholine on the heart. **Analysis of Incorrect Options:** * **A. Selective $M_1$ antagonist:** The prototypical selective $M_1$ antagonist is **Pirenzepine** (or Telenzepine). These are primarily found in gastric glands and autonomic ganglia. * **C. Selective $M_3$ antagonist:** Examples include **Darifenacin** and **Solifenacin**, used clinically for overactive bladder. $M_3$ receptors are located in smooth muscles, exocrine glands, and vascular endothelium. * **D. Nonselective agonist:** Nonselective muscarinic agonists include **Acetylcholine, Carbachol, and Bethanechol**. Methoctramine is strictly an antagonist, not an agonist. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Muscarinic Antagonists:** * **$M_1$:** **P**irenzepine (**P**rimary/First) * **$M_2$:** **M**ethoctramine (**M**iddle/Second) * **$M_3$:** **D**arifenacin (**D**ownstream/Third) * **Gallamine**, a neuromuscular blocker, also possesses significant $M_2$ antagonist properties, leading to tachycardia. * **Tripitramine** is another highly potent and selective $M_2$ blocker often mentioned in advanced pharmacology texts alongside Methoctramine.

Q: Which of the following enzymes does not affect plasma cholinesterase activity?

Edrophonium. ### Explanation The question focuses on the substrate specificity and binding characteristics of anticholinesterase drugs. There are two main types of cholinesterases in the body: **Acetylcholinesterase (AChE)**, found at neuromuscular junctions and synapses, and **Butyrylcholinesterase (BuChE)**, also known as **Plasma Cholinesterase** or Pseudocholinesterase. **Why Edrophonium is the correct answer:** Edrophonium is a short-acting quaternary ammonium compound that binds only to the **anionic site** of the enzyme via ionic bonding. It is highly selective for Acetylcholinesterase (AChE) and has **negligible effect on plasma cholinesterase**. Because its binding is reversible and non-covalent, its duration of action is very short (5–15 minutes), making it ideal for the Tensilon test. **Why the other options are incorrect:** * **Neostigmine & Pyridostigmine:** These are carbamates. Unlike edrophonium, they bind to both the **anionic and esteratic sites** of the enzyme, forming a carbamoylated complex. Carbamates are non-selective and inhibit **both** Acetylcholinesterase and Plasma Cholinesterase. Therefore, they do affect plasma cholinesterase activity. **NEET-PG High-Yield Pearls:** 1. **Tensilon Test:** Edrophonium is used to differentiate a Myasthenic crisis (improvement) from a Cholinergic crisis (worsening). 2. **Plasma Cholinesterase Clinical Significance:** This enzyme is responsible for the metabolism of **Succinylcholine**, Mivacurium, and Procaine. 3. **Drug of Choice:** Neostigmine is the drug of choice for reversing neuromuscular blockade (post-surgery) and paralytic ileus, while Pyridostigmine is the preferred maintenance drug for Myasthenia Gravis due to its longer duration of action. 4. **Organophosphates:** Unlike carbamates, these irreversibly inhibit both types of cholinesterases by phosphorylating the esteratic site.

Q: In the autonomic nervous system, which neurotransmitter is primarily associated with parasympathetic outflow?

Cholinergic. The autonomic nervous system (ANS) is divided into the sympathetic and parasympathetic divisions. The **parasympathetic nervous system (PNS)**, often referred to as the "rest and digest" system, utilizes **Acetylcholine (ACh)** as its primary neurotransmitter at both the preganglionic and postganglionic levels [1]. Therefore, the outflow is termed **Cholinergic**. * **Why Option A is correct:** In the parasympathetic system, long preganglionic fibers release ACh onto nicotinic receptors in the ganglia, and short postganglionic fibers release ACh onto muscarinic receptors at the effector organs [1]. * **Why Options B & C are incorrect:** Adrenergic and Noradrenergic refer to **Norepinephrine (Noradrenaline)** and Epinephrine [2]. These are the primary neurotransmitters for the **sympathetic nervous system** postganglionic neurons (except for sweat glands). * **Why Option D is incorrect:** Histaminergic neurons use Histamine as a neurotransmitter; while important in the CNS (wakefulness) and inflammatory responses, they do not mediate the primary outflow of the ANS. **High-Yield Clinical Pearls for NEET-PG:** 1. **Exceptions to the Rule:** All preganglionic fibers (both sympathetic and parasympathetic) are cholinergic [3]. However, sympathetic postganglionic fibers to **sweat glands** are also cholinergic (thermoregulatory sweating). 2. **The Adrenal Medulla:** This is essentially a modified sympathetic ganglion that releases Epinephrine (80%) and Norepinephrine (20%) directly into the blood. 3. **Mnemonic:** Remember **"P"** for **P**arasympathetic = **P**re- and **P**ost-ganglionic fibers are both cholinergic.

Q: Postural hypotension is seen with all EXCEPT?

Tamsulosin. **Explanation:** The primary mechanism behind postural (orthostatic) hypotension with alpha-blockers is the blockade of **$\alpha_1$-receptors** on vascular smooth muscle, leading to vasodilation and a failure of the compensatory baroreceptor reflex upon standing. **Why Tamsulosin is the correct answer:** Tamsulosin is a **selective $\alpha_{1A}$ subtype blocker**. The $\alpha_{1A}$ receptors are predominantly located in the prostate and bladder neck, whereas $\alpha_{1B}$ receptors are found in the vascular smooth muscle. Because Tamsulosin specifically targets the prostate and has minimal affinity for the vascular $\alpha_{1B}$ receptors, it causes significantly less peripheral vasodilation. Consequently, it is "uroselective" and carries a much lower risk of postural hypotension compared to non-selective $\alpha_1$ blockers. **Analysis of Incorrect Options:** * **Prazosin:** A short-acting, non-selective $\alpha_1$ blocker. It is notorious for the **"First Dose Phenomenon,"** where the initial dose causes severe orthostatic hypotension and syncope. * **Terazosin & Doxazosin:** These are long-acting, non-selective $\alpha_1$ blockers. While they are used for both Hypertension and Benign Prostatic Hyperplasia (BPH), they block vascular $\alpha_1$ receptors, frequently causing postural hypotension as a side effect. **NEET-PG High-Yield Pearls:** * **First-line for BPH:** Tamsulosin is preferred in normotensive elderly patients because it doesn't affect blood pressure. * **Silodosin:** Another highly selective $\alpha_{1A}$ blocker (even more selective than Tamsulosin); its unique side effect is **retrograde ejaculation**. * **Clinical Tip:** To minimize the "First Dose Phenomenon" with Prazosin, advise patients to take the starting dose at bedtime.

Q: Activation of postsynaptic M2 receptors on the heart is associated with:

Opening of K+ channels. **Explanation:** The Muscarinic M2 receptor is a **G-protein coupled receptor (GPCR)** primarily located in the heart (SA node, AV node, and atria). It is coupled with the **Gi/o (inhibitory)** protein. **1. Why Option B is the Correct Answer:** When Acetylcholine binds to M2 receptors, the G-protein dissociates into its subunits. The **Gβγ subunit** directly interacts with and opens **G-protein-coupled Inwardly Rectifying Potassium (GIRK) channels**. This leads to an efflux of K+ ions, causing **hyperpolarization** of the nodal cells. This hyperpolarization slows the rate of spontaneous depolarization (Phase 4), resulting in a decreased heart rate (negative chronotropy) and slowed conduction velocity (negative dromotropy). **2. Why the other options are incorrect:** * **Option A & C:** M2 receptors are coupled to **Gi**, which **inhibits** adenylyl cyclase. Therefore, it leads to a *decrease* in cAMP formation, not an activation of the enzyme. While cAMP does decrease (Option C), the *primary* and most immediate mechanism for the cardiac inhibitory effects (especially hyperpolarization) is the opening of K+ channels. In many standard medical examinations, the direct ion channel effect is prioritized as the hallmark of M2 activation. * **Option D:** Increase in IP3 and DAG is the signaling pathway for **Gq-coupled** receptors (**M1, M3, and M5**). **NEET-PG High-Yield Pearls:** * **M1, M3, M5:** Gq-coupled (IP3/DAG pathway). * **M2, M4:** Gi-coupled (Inhibits Adenylyl Cyclase/Opens K+ channels). * **Vagal Stimulation:** Acts via M2 receptors to cause bradycardia. * **Atropine:** A muscarinic antagonist used to treat sinus bradycardia by blocking these M2 receptors.

Q: Which muscle relaxant has a ganglion blocker action?

Curare. **Explanation:** The correct answer is **Curare (d-Tubocurarine)**. **1. Why Curare is correct:** Curare (specifically d-tubocurarine) is a non-depolarizing neuromuscular blocking agent. Its primary mechanism is the competitive blockade of nicotinic receptors at the motor endplate ($N_m$ receptors). However, it lacks absolute selectivity and also blocks nicotinic receptors at the autonomic ganglia ($N_n$ receptors). This **ganglion-blocking action** leads to a fall in blood pressure and tachycardia, which is further exacerbated by its ability to trigger **histamine release**. **2. Why the other options are incorrect:** * **Pancuronium:** This is a long-acting non-depolarizing blocker. Unlike curare, it does not cause ganglion blockade or histamine release. Instead, it has **vagolytic (antimuscarinic)** properties, which typically cause tachycardia and hypertension. * **Trimethoprim:** This is an antimicrobial agent (dihydrofolate reductase inhibitor) used in treating infections. It has no muscle relaxant or ganglion-blocking properties. * **Halothane:** This is an inhaled general anesthetic. While it causes muscle relaxation (by potentiating GABA and inhibiting glutamate), it does so via CNS depression and does not act as a nicotinic ganglion blocker. **High-Yield Clinical Pearls for NEET-PG:** * **d-Tubocurarine** is rarely used today due to its side effects: **Hypotension** (due to ganglion blockade + histamine release) and **Bronchospasm** (due to histamine). * **Atracurium/Cisatracurium:** Preferred in patients with liver/kidney failure as they undergo **Hofmann elimination** (spontaneous degradation). * **Mivacurium:** The shortest-acting non-depolarizing blocker, metabolized by plasma cholinesterase. * **Succinylcholine:** The only depolarizing blocker used clinically; known for causing hyperkalemia and malignant hyperthermia.

Q: Which of the following drugs can cross the blood-brain barrier?

Physostigmine. ### Explanation The ability of a drug to cross the Blood-Brain Barrier (BBB) is primarily determined by its chemical structure, specifically its lipid solubility and ionization state. **1. Why Physostigmine is Correct:** Physostigmine is a **tertiary amine**. Unlike many other cholinesterase inhibitors, tertiary amines are non-polar and highly lipid-soluble. This allows them to easily penetrate the BBB and exert central nervous system (CNS) effects. Clinically, this property makes Physostigmine the drug of choice for treating **Atropine poisoning**, as it can reverse both peripheral and central anticholinergic symptoms. **2. Why the Other Options are Incorrect:** * **Neostigmine:** This is a **quaternary ammonium compound**. Quaternary amines are permanently charged (ionized) and polar, which makes them lipid-insoluble. Consequently, Neostigmine cannot cross the BBB and acts only on peripheral tissues (e.g., the neuromuscular junction in Myasthenia Gravis). * **Acarbose:** This is an alpha-glucosidase inhibitor used in the management of Type 2 Diabetes Mellitus. It is a complex oligosaccharide that acts locally within the gastrointestinal tract to delay carbohydrate absorption; it is poorly absorbed systemically and does not cross the BBB. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** **P**hysostigmine **P**enetrates the CNS; **N**eostigmine **N**o (does not). * **Organophosphate Poisoning:** While Physostigmine is a carbamate, it is generally avoided in OP poisoning; Atropine and Pralidoxime (2-PAM) are the mainstays. * **Quaternary Amines (No CNS entry):** Neostigmine, Pyridostigmine, Edrophonium, and Ipratropium. * **Tertiary Amines (CNS entry):** Physostigmine, Rivastigmine, Donepezil, and Galantamine (the latter three are used in Alzheimer’s disease for their central action).

Q: Clonidine has the following attributes except:

Can produce CNS stimulation. **Explanation:** Clonidine is a centrally acting **$\alpha_2$-adrenergic agonist** used primarily as an antihypertensive. The correct answer is **C** because Clonidine is a potent **CNS depressant**, not a stimulant. **1. Why Option C is correct:** Clonidine stimulates $\alpha_{2A}$ receptors in the nucleus tractus solitarius (NTS) of the medulla. This decreases sympathetic outflow from the vasomotor center, leading to sedation, drowsiness, and reduced mental alertness. It is never associated with CNS stimulation. **2. Analysis of Incorrect Options:** * **Option A:** Clonidine is a selective partial agonist of **presynaptic $\alpha_2$ receptors**. Stimulation of these receptors inhibits the release of norepinephrine (negative feedback), leading to a fall in blood pressure. * **Option B:** Abrupt withdrawal of Clonidine causes a "rebound" phenomenon. This occurs due to the sudden surge of catecholamines and up-regulation of receptors during treatment, leading to severe hypertension, tachycardia, and anxiety. * **Option D:** Dry mouth (xerostomia) is a common side effect. It occurs because $\alpha_2$ stimulation in the CNS and locally on salivary glands inhibits parasympathetic-mediated salivation. **Clinical Pearls for NEET-PG:** * **Imidazoline Receptors:** Clonidine also acts on $I_1$ imidazoline receptors in the medulla, contributing to its antihypertensive effect. * **Other Uses:** Apart from hypertension, it is used in opioid withdrawal, ADHD, nicotine de-addiction, and prophylaxis of migraine. * **Diagnostic Test:** The **Clonidine Suppression Test** is used to diagnose Pheochromocytoma (it fails to suppress catecholamines in affected patients).

Question 1

Which enzymes are involved in the degradation of epinephrine?

Accepted Answer

Catechol-O-methyltransferase

Answer

Cholinesterase

Answer

Anticholinesterases

Answer

Oxidases

Question 2

Methoctramine is a

Accepted Answer

Selective M2 antagonist

Answer

Selective M1 antagonist

Answer

Selective M3 antagonist

Answer

Nonselective (M1+M2) agonist

Question 3

Which of the following enzymes does not affect plasma cholinesterase activity?

Accepted Answer

Edrophonium

Answer

Neostigmine

Answer

Pyridostigmine

Answer

All

Question 4

In the autonomic nervous system, which neurotransmitter is primarily associated with parasympathetic outflow?

Accepted Answer

Cholinergic

Answer

Adrenergic

Answer

Noradrenergic

Answer

Histaminergic

Question 5

Postural hypotension is seen with all EXCEPT?

Accepted Answer

Tamsulosin

Answer

Prazosin

Answer

Terazosin

Answer

Doxazosin

Question 6

Activation of postsynaptic M2 receptors on the heart is associated with:

Accepted Answer

Opening of K+ channels

Answer

Activation of adenylyl cyclase

Answer

Decrease in cAMP formation

Answer

Increase in IP3 and DAG

Question 7

Which muscle relaxant has a ganglion blocker action?

Accepted Answer

Curare

Answer

Pancuronium

Answer

Trimethoprim

Answer

Halothane

Question 8

Which of the following drugs can cross the blood-brain barrier?

Accepted Answer

Physostigmine

Answer

Neostigmine

Answer

Acarbose

Answer

All of the above

Question 9

Clonidine has the following attributes except:

Accepted Answer

Can produce CNS stimulation

Answer

Acts on alpha2 adrenergic receptors

Answer

Can produce rebound hypertension on abrupt withdrawal

Answer

Inhibits salivation

Question 10

An 11-year-old boy was brought to the ER by his friends because he started acting erratically after eating seeds from a plant while attempting to achieve intoxication. The boy was incoherent with hot and dry skin. His pupils were dilated and unresponsive to light. His blood pressure was 180/105 mm Hg, pulse 150/min, and rectal temperature was 40°C (104°F). What is the most likely diagnosis given the symptoms?

Accepted Answer

Belladonna alkaloid poisoning

Answer

Digoxin toxicity

Answer

Phencyclidine intoxication

Answer

Cannabis intoxication

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?